Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/23/2010US20100324135 Disinfectant and method of making
12/23/2010US20100324132 Methods and compositions for promoting wound healing
12/23/2010US20100324125 Proteins derived from white spot syndrome virus and uses thereof
12/23/2010US20100324123 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
12/23/2010US20100324117 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use
12/23/2010US20100324110 Self Solidifying Bioerodible Barrier Implant
12/23/2010US20100324109 Composition for Topical Use
12/23/2010US20100324108 Substituted isoindoline-1,3-dione derivatives
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324067 Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities
12/23/2010US20100324060 Pharmaceutical compositions useful for treating hcv
12/23/2010US20100324059 Pharmaceutical compositions useful for treating hcv
12/23/2010US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324034 Methods of Using SAHA for Treating HIV Infection
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323998 Topical composition containing the combination of mupirocin and beclomethasone
12/23/2010US20100323989 Pharmaceutical combinations useful for treating hcv
12/23/2010US20100323974 Inhibitors of PARP Activity and Uses Thereof
12/23/2010US20100323973 Conjugates containing hydrophilic spacer linkers
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323960 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323959 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323958 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323953 Macrocyclic hepatitis c protease inhibitors
12/23/2010US20100323952 Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
12/23/2010US20100323951 Antibacterial peptides active in systemic infections
12/23/2010US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
12/23/2010US20100323949 erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323036 Nitric Oxide Therapies
12/23/2010US20100323024 Puumala virus full-length m segment-based dna vaccines
12/23/2010US20100323013 Hydrolysates made of plant extracts and antibacterial agent containing the same
12/23/2010US20100323007 A polyamide rate-modulated monolithic drug delivery system
12/23/2010US20100323001 In Vivo Delivery Of Double Stranded RNA To a Target Cell
12/23/2010US20100322989 Hydrophilic skin cleaning cloth
12/23/2010US20100322986 Compositions and devices
12/23/2010US20100322985 Effervescent compositions
12/23/2010US20100322975 Anti-bacterial Vaccine Compositions
12/23/2010US20100322974 Targeting the histone code as a bacterial strategy for selectively modulating gene expression
12/23/2010US20100322972 HCV Vaccines For Chronic HCV Patients
12/23/2010US20100322971 Method for producing vaccinal viral strain of a virus of the reoviridae family
12/23/2010US20100322970 Modified influenza virus
12/23/2010US20100322969 Influenza b viruses having alterations in the hemaglutinin polypeptide
12/23/2010US20100322968 Therapeutic agent for cancer
12/23/2010US20100322966 Method for allogeneic cell therapy
12/23/2010US20100322965 Viral vaccine vectors
12/23/2010US20100322962 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
12/23/2010US20100322958 Modified saccharides
12/23/2010US20100322957 Secretion-related bacterial proteins for nlrc4 stimulation
12/23/2010US20100322955 Virulence genes, proteins, and their use
12/23/2010US20100322954 Enhanced hiv-1 vaccines and methods for their use
12/23/2010US20100322951 Replication-proficient dsRNA capsids and uses thereof
12/23/2010US20100322944 Anti-bacterial antibodies
12/23/2010US20100322943 Therapeutic and diagnostic affinity purified specific polyclonal antibodies
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322927 Glycosylated antibodies
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322910 Methods of obtaining antigen-specific t cell populations
12/23/2010US20100322903 Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010US20100322896 Molecular adjuvant
12/23/2010US20100322891 Immuniostimulating polyphosphazene compounds
12/23/2010US20100322878 Personal Care Composition Comprising a Synthetic Cationic Polymer
12/23/2010US20100322874 Absorbant/compliant solution-free cleaning and multiactive compositions
12/23/2010US20100322872 Novel methods and medicament for treating infectious diseases involving microbial biofilms
12/23/2010US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
12/23/2010CA2776883A1 Antimicrobial and antibiofilm activity of cathelicidins
12/23/2010CA2765696A1 Solution containing hypochlorous acid and methods of using same
12/23/2010CA2765657A1 Anti-gram-negative bacteria agent
12/23/2010CA2765448A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010CA2765423A1 Casein derived protease inhibitory peptides
12/23/2010CA2765380A1 Connection device for a submersible connector
12/23/2010CA2764177A1 Inhibitors of influenza viruses replication
12/23/2010CA2761568A1 Structured viral peptide compositions and methods of use
12/22/2010EP2264176A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
12/22/2010EP2264046A1 Artificial CpG single-stranded oligodeoxynucleotide and antiviral use thereof
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263688A1 Neisseria meningitidis combination vaccines
12/22/2010EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
12/22/2010EP2263676A1 Anti-Hepatitis C composition and method for preparing drug for inhibiting Hepatitis C viruses or treating Hepatitis C
12/22/2010EP2263671A1 Amide derivative-containing pharmaceutical composition
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2263654A1 Compositions and methods to improve the oral absorption of antimicrobial agents
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1798